Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Salivary gland neoplasms.

Terry A Day1, John Deveikis, M Boyd Gillespie

  • 1Head and Neck Tumor Program, Hollings Cancer Center, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA. dayt@musc.edu

Current Treatment Options in Oncology
|December 31, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor and Stromal Sphingolipid Imbalance Are Associated with T Cell Tissue Residency in Glioblastoma.

Cancers·2026
Same author

Cardio-Protective Effect of GLP-1 Agonists in OSA Patients: A Study of Cardiovascular Risk.

Laryngoscope investigative otolaryngology·2026
Same author

Proteomic analysis of sphingolipid metabolic enzymes with risk of bladder cancer incidence and mortality in the Atherosclerosis Risk in Communities (ARIC) Study.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Proteome Responses to Acute Inhibition of De Novo Sphingolipid Synthesis Suggest Cancer Combination Therapies.

Cancers·2026
Same author

Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

Nature communications·2026
Same author

Effect of Malocclusion on Response to Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea.

Laryngoscope investigative otolaryngology·2026

Surgical intervention, primarily superficial parotidectomy, is key for salivary gland neoplasms. Radiation therapy is used for high-grade malignancies, while chemotherapy shows limited benefits for salivary gland cancer.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Salivary gland neoplasms necessitate surgical treatment in most instances.
  • Superficial parotidectomy with facial nerve preservation is the standard surgical approach for parotid neoplasms.
  • High-grade malignancies and those with recurrence risk require postoperative radiation therapy.

Purpose of the Study:

  • To outline the current treatment strategies for salivary gland neoplasms.
  • To discuss the role of surgery, radiation, and chemotherapy in managing these tumors.
  • To highlight advancements in radiation therapy for reducing treatment morbidity.

Main Methods:

  • Review of current treatment modalities for salivary gland neoplasms.
  • Discussion of surgical techniques, including superficial parotidectomy.

Related Experiment Videos

  • Analysis of the indications and effectiveness of radiation and chemotherapy.

    • Main Results:

    • Surgery is the primary treatment for most salivary gland neoplasms.
    • Radiation therapy is crucial for high-grade and recurrent malignancies.
    • Chemotherapy has not demonstrated significant survival or quality-of-life benefits.

    Conclusions:

    • Surgical intervention remains the cornerstone of salivary gland neoplasm treatment.
    • Radiation therapy plays a vital role in managing advanced or recurrent disease.
    • Advancements in radiation techniques like intensity-modulated radiation therapy offer improved outcomes with reduced side effects.